Sharapova suspension leaves her sponsors in a quandary

The International Tennis Federation announced the athlete’s punishment for unintentionally doping. Some companies lent support; others kept their distance.

Ragan Insider Premium Content
Ragan Insider Content

On Wednesday, the International Tennis Federation announced that it was suspending Sharapova for two years for taking the performance-enhancing drug meldonium .

The New York Times explained:

After a hearing May 18 and 19, a three-member tribunal appointed by the I.T.F. ruled that while Sharapova’s doping violation was not intentional, “she does bear sole responsibility for the contravention, and very significant fault, in failing to take any steps to check whether the continued use of this medicine was permissible.”

To read the full story, log in.
Become a Ragan Insider member to read this article and all other archived content.
Sign up today

Already a member? Log in here.
Learn more about Ragan Insider.